Concepedia

Andreas Kaiser

AK

12

Publications

321

Citations

11

H-Index

2009

Active since

Affiliations

Bayer (Germany)(Current)

St. Josef-Hospital

Bayer (Japan)

Bayer (United States)

Ruhr University Bochum

Andreas Kaiser is an author at Bayer (Germany) specializing in medicine, cardiovascular disease, and thrombosis.

ORCID

Top concepts

Publications per year

2009–2021

12

Publications

12

Which is the best anticoagulant for whole blood aggregometry platelet function testing? Comparison of six anticoagulants and diverse storage conditions

Andreas Kaiser, H. Neubauer, Cora Christina Franken et al. · Platelets · 2011 · 64 citations

, , +22

Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy women

Barbara Schütt, Andreas Kaiser, Marcus‐Hillert Schultze‐Mosgau et al. · Human Reproduction · 2016 · 43 citations · Full text

First‐in‐man–proof of concept study with molidustat: a novel selective oral HIF‐prolyl hydroxylase inhibitor for the treatment of renal anaemia

M. Böttcher, Silvia Lentini, Erich R. Arens et al. · British Journal of Clinical Pharmacology · 2018 · 37 citations · Full text

Adenocarcinoma Arising in the Middle of Ileoanal Pouches

Glenn T. Ault, Joseph W. Nunoo‐Mensah, Laura Johnson et al. · Diseases of the Colon & Rectum · 2009 · 35 citations

, , +14

Effect of the Novel Selective Progesterone Receptor Modulator Vilaprisan on Ovarian Activity in Healthy Women

Barbara Schütt, Marcus‐Hillert Schultze‐Mosgau, Corinna Draeger et al. · The Journal of Clinical Pharmacology · 2017 · 26 citations · Full text

Rows per page

1–5 of 12